Abstract
Two new APP substrate-based hydroxyethylene isosteres (AT and VI) were prepared and their dipeptide conjugates shown not to inhibit the gamma-secretase-mediated formation of either Abeta1-40 or Abeta1-42. The FG isostere and a des-hydroxy hydroxyethylene isostere also gave inactive compounds. Conversely, a number of compounds containing the intact substrate-unrelated Phe-Phe (FF) hydroxyethylene isostere were shown to be potent inhibitors (ED(50)=14-732 nM). These results show that the factors governing the substrate-based design of gamma-secretase inhibitors are more complicated than first thought.
MeSH terms
-
Amyloid Precursor Protein Secretases
-
Amyloid beta-Peptides / biosynthesis
-
Amyloid beta-Protein Precursor / chemistry*
-
Aspartic Acid Endopeptidases
-
Dipeptides / chemical synthesis
-
Dipeptides / chemistry
-
Dipeptides / pharmacology*
-
Endopeptidases / drug effects*
-
Endopeptidases / metabolism
-
Ethylenes
-
Humans
-
Inhibitory Concentration 50
-
Molecular Mimicry
-
Protease Inhibitors / chemical synthesis*
-
Protease Inhibitors / pharmacology
-
Structure-Activity Relationship
Substances
-
Amyloid beta-Peptides
-
Amyloid beta-Protein Precursor
-
Dipeptides
-
Ethylenes
-
Protease Inhibitors
-
hydroxyethylene
-
Amyloid Precursor Protein Secretases
-
Endopeptidases
-
Aspartic Acid Endopeptidases
-
BACE1 protein, human